Early clinical experience of transcatheter aortic valve implantation via apical approach for high-risk aortic valve disease in single-center
- VernacularTitle:单中心经心尖途径 TAVI 治疗高危主动脉瓣病变早期临床经验
- Author:
ZHANG Li
1
;
WANG Pingfan
1
;
WANG Fengling
1
;
LI Yuzhen
1
;
LIU Haixia
1
;
LIU Jianhua
1
;
LIU Xuping
1
;
XIAO Changbo
1
;
GAO Xia
1
;
WU Gang
1
;
ZHANG Xianghui
1
;
CUI Cong
1
;
CHEN Yuxin
1
;
ZHENG Yi
1
Author Information
- Publication Type:Journal Article
- Keywords: Aortic valve disease; transcatheter aortic valve implantation; heart apex approach; high-risk severe disease
- From: Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2019;26(12):1194-1198
- CountryChina
- Language:Chinese
- Abstract: Objective To summarize the clinical experience in the treatment of high-risk patients with severe aortic valve disease by transcatheter aortic valve implantation (TAVI) via heart apex approach and to evaluate the early efficacy. Method Five patients who underwent TAVI via heart apex approach from September 2017 to February 2019 in Henan Thoracic Hospital were retrospectively analyzed, including 3 males and 2 females, aged 65-84 (74.6±4.5) years. Result All operations were performed through a small left incision into the thoracic cavity (3-5 cm), and then through the J-Valve transport system, the aortic valve was successfully released via heart apex after precise positioning under digital subtraction angiography. One patient developed ventricular fibrillation during the operation, and the operation was completed with the assistance of emergency femoral arteriovenous catheterization cardiopulmonary bypass; one patient underwent percutaneous coronary intervention first because of severe coronary stenosis; one patient had paroxysmal atrial fibrillation during the perioperative period, and had hepatorenal insufficiency and thrombocytopenia after the operation, and was improved after medical treatment; one patient had perivalvular leak during the operation, and was improved after re-implantation of the valve; one patient was in stable condition during operation and recovered smoothly after operation. Surgery was successful in all 5 patients. The follow-up time was 2-19 months, and the early clinical effect was good. Conclusion The short-term clinical efficacy of TAVI via heart apex approach in the treatment of high-risk severe aortic valve disease is definite and safe, but the long-term and medium-term effects need to be further evaluated.
